Evolent Health Announces Cooperation Agreement With Engaged Capital
Appoints New Independent Director Craig Barbarosh to the Board
Board to Form a Strategy Committee Focused on Value Creation Initiatives
Company to Seek Stockholder Approval to Declassify Board at 2021 Annual Meeting
News provided by
Share this article
Share this article
WASHINGTON, Dec. 22, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (the "Company" or "Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it has entered into a Cooperation Agreement with Engaged Capital, LLC ("Engaged Capital"), pursuant to which Craig Barbarosh has been appointed to Evolent's Board of Directors as a Class III director.